The company had a consolidated net profit of Rs 43.41 crore in the first quarter last FY'08, Piramal Healthcare said in a filing to Bombay Stock Exchange (BSE).
The consolidated total income rose to Rs 708.43 crore in the latest quarter, from Rs 610.09 crore in the year-ago period.
Piramal Healthcare posted standalone net profit of Rs 50.94 crore for the quarter ended June 30, a 48.08 per cent growth over the last year net profit, which stood at Rs 34.4 crore.
Total income of the company rose to Rs 489.22 crore, a 23.19 per cent increase from Rs 397.10 crore in the quarter last year.
The company has provided Rs 20.82 crore towards market-to-market unrealised loss on outstanding foreign currency borrowing, and realised forex loss of Rs 2.14 crore.
PHL grew particularly well in the cardio-vascular, dermatology, anti-infectives and respiratory therapy segments and has expanded its footprint in the diagnostic services business, Piramal Healthcare said.
Shares of the company closed at Rs 297.65, up 0.35 per cent on BSE.
